Bill > SB562

This bill expands the types of healthcare professionals who can enter into agreements with pharmacists for medication management and treatment, specifically allowing licensed certified midwives to participate in these therapy management contracts. It also removes the requirement for authorized prescribers, such as physicians, to submit their prescriber-pharmacist agreements to the specific health occupations board that regulates them, instead directing pharmacists to submit these agreements and any updates to the Board of Pharmacy. Crucially, the bill authorizes pharmacists, under specific conditions, to enter into these agreements to treat opioid use disorders using controlled dangerous substances drug therapy, provided they are individually registered with federal and state controlled substance agencies, complete required training, and follow a protocol that includes checking the Prescription Drug Monitoring Program before initiating or modifying such therapy.